Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 56, Issue 1, 2005, Pages 105-114

  Perumal, Selvanathan Saravana ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanadham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Breast cancer; Cancer cachexia; Carbohydrate metabolizing enzymes; Energy modulating vitamins; Tamoxifen

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARBOHYDRATE METABOLIZING ENZYME; CYTOCHROME C OXIDASE; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCOLYTIC ENZYME; HEXOKINASE; ISOCITRATE DEHYDROGENASE; ISOENZYME; MALATE DEHYDROGENASE; NICOTINIC ACID; OXOGLUTARATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOFLAVIN; SUCCINATE DEHYDROGENASE; TAMOXIFEN; UBIDECARENONE; UNCLASSIFIED DRUG; VITAMIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST CANCER; BREAST CARCINOMA; CARBOHYDRATE METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG EFFICACY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; MAMMARY GLAND; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ANIMAL; CACHEXIA; CARCINOMA; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CACHEXIA; CARBOHYDRATE METABOLISM; CARCINOMA; CITRIC ACID CYCLE; ENERGY METABOLISM; FEMALE; MAMMARY NEOPLASMS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN; VITAMINS;

EID: 21244488903     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0943-6     Document Type: Article

References (58)

1. Golshani-Hebroni SG, Bessman SP (1997) Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J Bioenerg Biomembr 29:331-338
2. Baggetto LG (1992) Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74:959-974
3. Pederson PL (1978) Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 22:190-274
4. Waterhouse C (1974) Lactate metabolism in patients with cancer cachexia. Cancer 33:66-71
5. Fenninger LD, Mider GB (1954) Energy and nitrogen metabolism in cancer. Adv Cancer Res 2:229-252
6. Stein TP (1978) Cachexia, gluconeogenesis and progressive weight loss in cancer patients. J Theor Biol 73:51-59
7. Parlo RA, Coleman PS (1984) Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. J Biol Chem 259:9997-10003
8. Tisdales MJ (1997) Biology of cachexia. J Natl Cancer Inst 89:1763-1773
9. McPherson K, Steel CM, Dixon JM (2000) ABC of the breast diseases, breast cancer epidemiology, risk factors and genetics. BMJ 321:624-628
10. Parton M, Dowsett M, Smith I (2001) Studies of apoptosis in breast cancer. BMJ 322:1528-1532
11. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornande T, Wilking N (1995) Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 87:645-651
12. Saez RA, Osborne CK (1989) Hormonal treatment of advanced breast cancer. In: Kennedy BJ (ed) Current clinical oncology. Alan R Liss, New York, pp 163-172
13. Jordan VC (1993) A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 110:507-517
14. O'Brian CA, Liskam RM, Solomon DH, Weinstein IB (1985) Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465
15. Lam HY (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118:27-32
16. Han X, Liehr JG (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 52:1360-1363
17. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM (1994) Endometrial cancer in tamoxifen treated breast cancer patients. J Natl Cancer Inst 86:527-537
18. McCormick DB (1999) Riboflavin. In: Shils M, Olson JA, Shike M, Ross AC (eds) Nutrition in health and disease. Williams & Wilkins, Baltimore, pp 391-399
19. Jacobson EL, Jacobson MK (1993) A biomarker for the assessment of niacin nutriture as a potential preventive factor in carcinogenesis. J Int Med 233:59-62
20. 10 concentration in breast cancer: prognosis and therapeutic consequence. Int J Clin Pharm Ther 36:506-509
21. Sujatha V, Muthumanickam V, Rani G, Sachdanandam P (1999) Effect of Semecarpus anacardium Linn, nut extract on glucose metabolizing enzymes in experimentally induced mammary carcinoma in rats. J Pharm Pharmacol 51:241
22. Geren RJ, Greenberg NH, McDonald MM, Schumacher AM (1972) Protocols for screening chemical agents and natural products against animal tumours and other biological system. Cancer Chemother Rep 3:103
23. Roberto LC, Edward WB, Jerry AP (1987) Experimental immunotherapy of human breast carcinoma implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components. Cancer Res 47:532
24. Lowry OH, Rosenbrough NJ, Farr AI, Randall RJ (1951) Protein determination using folin ciocalteau reagent. J Biol Chem 193:265-275
25. Senior AE, McGowan SE, Hilf R (1975) A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland. Cancer Res 35:2061-2067
26. Branstrup N, Kirk JE, Bruni C (1957) Hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 12:166-170
27. Horrocks JE, Ward J, King J (1963) A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol 16:248-251
28. King J (1965) The transferase alanine and aspartate transaminase. In: Practical clinical enzymology. D Van Nostrand, London, pp 121-138
29. Gancedo JM, Gancedo C (1971) Fructosel,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Microbiol 76:132-138
30. King J (1965) The dehydrogenases or oxidoreductase lactate dehydrogenase. In: Practical clinical enzymology. D Van Nostrand, London, pp 83-93
31. King J (1965) Transferases. In: Practical clinical enzymology. D Van Nostrand, London, p 263
32. Reed LJ, Mukherjee BB (1969) α-Ketoglutarate dehydrogenase complex from Escherichia coli. Methods Enzymol 13:55-61
33. Slater EC, Bonner WD (1952) Effect of fluoride on succinate oxidase system. Biochem J 52:185-196
34. Mehler AH, Kornberg A, Grisolia S, Ochoa S (1948) The enzymatic mechanisms of oxidation reduction between malate or isocitrate and pyruvate. J Biol Chem 174:961-977
35. Minakami S, Ringer RL, Singer TP (1962) Studies on respiratory chain linked dihydrodiphosphopyridine nucleotide dehydrogenase. J Biol Chem 237:569-576
36. Wharton DC, Tzagoloff A (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 10:245-250
37. Parry DM, Pedersen PL (1983) Intracellular localization and properties of particulate hexokinase in the Novikoof ascites tumour. Evidence for an outer mitochondrial membrane location. J Biol Chem 258:10904-10912
38. Arora KK, Pedersen PL (1988) Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem 263:17422-17428
39. Rempel A, Bannasch P, Mayer D (1994) Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochem Biophys Acta 1219:660-668
40. Johansson T, Berrez JM, Nelson BD (1985) Evidence that transcription of the rat hexokinase gene is increased in a rapidly growing rat hepatoma. Biochem Biophys Res Commun 133:608-613
41. Gumaa KA, McLean PA (1969) A possible interrelationship between binding of hexokinase and the site of ATP formation in Krebs ascites cells. Biochem Biophys Res Commun 36:771-779
42. Fanciulli M, Paggi MG, Bruno T, Del Carlo C, Bonetto F, Gentile FP, Floridi A (1994) Glycolysis and growth rate in normal and in hexokinase transfected NIH-3T3 cells. Oncol Res 6:405-409
43. Hennipman A, Smits J, Van Oirschot B, Van Houwelingen JC, Rijsken G, Neyt JP, Van Unnik JA, Staal JE (1978) Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol 8 [Suppl 5]:251-263
44. Campbell DM, King EJ (1962) Serum phosphatases and glycolytic enzymes in cancer of the breast. Biochemistry 82:23-28
45. Mazurek S, Zwerschke W, Jansen-Duerr P, Eigenbrodt E (2001) Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic enzymes complex. Biochem J 356:247-256
46. Holroyde CP, Gabuzda TG, Putnam RC, Paul P, Reichard GA (1975) Altered glucose metabolism in metastatic carcinoma. Cancer Res 35:3710-3714
47. Lippert M, Papadopoulos N, Javadpour NR (1981) Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology 18:50-53
48. Rogers K, Roberts GM, Williams GT (1981) Gastric juice enzymes. An aid in the diagnosis of gastric cancer? Lancet 1:1124-1125
49. Helmes MH, Modia A, Abd El-Moneim, Moustafe MS, Abd EI-Balc, Safinoz MEL (1998) Clinical value of serum LDH, ceruloplasmin, cathepsin-D and lipid bound sialic acid in monitoring patients with malignant lymphomas. Med Sci Res 26:613-617
50. Schwartz MK (1992) Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta 206:77-82
51. Deshpande N, Mitchell I, Maltinti M, Boi A, Di Martino L (1985) The effect of the administration of tamoxifen, ethynyl oestradiol and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo. Br J Cancer 52:241-244
52. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL (1997) Targeting gene expression to hypoxic tumour cells. Nat Med 3:515-520
53. Lockwood K, Moesgaard S, Folkers K (1994) Partial and complete regression of breast cancer inpatients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun 199:1504-1508
54. Baggetto L (1993) Role of mitochondria in carcinogenesis. Eur J Cancer 29A [Suppl 1]:156-159
55. Powers HJ (1999) Current knowledge concerning optimal nutrition status of riboflavin, niacin and pyridoxine. Proc Nutri Soc 58:435-440
56. Littarru GP (1994) Energy and defense. Facts and perspectives on coenzyme Q10 in biology and medicine. Casa Editrice Scientifica Internazionale, Rome, pp 1-91
57. Costa G, Lane WW, Vincint RG, Siebold JA, Aragon M, Bewley PT (1980) Weight loss and cachexia in lung cancer. Nutr Cancer 2:98-104
58. Hyltander A, Drott C, Korner U, Sandstrom R, Lundholm K (1991) Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27:9-15